Name | 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid,hydrate,hydrochloride |
---|---|
Synonyms |
Actira
Moxifloxacin hydrochloride monohydrate UNII-B8956S8609 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrochloride hydrate 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride, hydrate (1:1:1) |
Description | Moxifloxacin (BAY 12-8039) hydrochloride monohydrate is an orally active bacterial inhibitor that is effective against Streptococcus pneumoniae. Moxifloxacin hydrochloride monohydrate can be used in tuberculosis research[1][2]. |
---|---|
Related Catalog | |
References |
Melting Point | 243-246°C dec. |
---|---|
Molecular Formula | C21H27ClFN3O5 |
Molecular Weight | 455.91 |
Exact Mass | 455.162323 |
PSA | 93.03000 |
LogP | 3.50200 |
Vapour Pressure | 4.56E-17mmHg at 25°C |
Storage condition | -20°C Freezer |
RTECS | VB1983750 |
---|
Precursor 0 | |
---|---|
DownStream 1 | |